-+ 0.00%
-+ 0.00%
-+ 0.00%

Goldman Sachs Maintains Buy on Legence, Raises Price Target to $52

Benzinga·01/28/2026 17:27:23
Listen to the news
Goldman Sachs analyst Adam Bubes maintains Legence (NASDAQ:LGN) with a Buy and raises the price target from $46 to $52.